NATIONAL COMMUNITY PHARMACISTS ASSOCIATION for NATIONAL COMMUNITY PHARMACISTS ASSOCIATION
What was lobbied
8 issue areas, each in the filer's own words, with who lobbied on it and where.
Animals ANI
Issues related to compounded pharmaceuticals for animals;
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Alcohol and Drug Abuse ALC
Implementation of Public Law 114-198 pharmacy provisions; Implementation of Public Law 114-255 pharmacy provisions;
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Taxation/Internal Revenue Code TAX
Small Business Tax Reform; H.R. 631, Death Tax Repeal Act of 2017; S. 205, Death Tax Repeal Act of 2017
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Defense DEF
TRICARE Pharmacy Benefit Provisions; Supporting implementation of Sec. 745 of National Defense Authorization Act for Fiscal Year 2017;
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Health Issues HCR
H.R. 1628, American Health Care Act; Issues related to legislation repealing and replacing the affordable care act; S. 637, Creating Transparency to Have Drug Rebates Unlocked (C-Thru) Act of 2017; S. 222, The Obama Care Replacement Act' S. 469, Affordable and Safe Prescription Drug Importation Act; H.R. 1245, Affordable and Safe Prescription Drug Importation Act; H.R. 1776, Improving Access to Affordable Prescription Drugs Act; S. 771, Improving Access to Affordable Prescription Drugs Act; H.R. 242, Medicare Prescription Drug Price Negotiation Act of 2017; S. 41, Medicare Prescription Drug Price Negotiation Act of 2017;
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Medicare/Medicaid MMM
H.R. 1316, Prescription Drug Price Transparency Act; H.R. 1038, Improving Transparency and Accuracy in Medicare Part D Spending Act; S. 413, Improving Transparency and Accuracy in Medicare Part D Spending Act; H.R. 592, Pharmacy and Medically Underserved Areas Enhancement Act; S. 109, Pharmacy and Medically Underserved Areas Enhancement Act; H.R.1939 - To amend title XVIII of the Social Security Act to ensure equal access of Medicare beneficiaries to community pharmacies in underserved areas as network pharmacies under Medicare prescription drug coverage, and for other purposes
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Budget/Appropriations BUD
Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act; Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Appropriations Act, specifically FDA funding for implementation of the Drug Quality and Security Act.
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Pharmacy PHA
Congressional Oversight of 340 B Program; Issues related to FDA implementation of The Drug Quality and Security Act related to the regulations of pharmacy compounding; Biosimilar naming; H.R. 421 Allowing Greater Access to Safe and Effective Contraception Act
| Lobbyist | Covered position, as disclosed |
|---|---|
| RONNA HAUSER | — |
| KARRY LA VIOLETTE | — |
| SUSAN PILCH | — |
| MICHAEL TOMBERLIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.